Manchester Capital Management’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.4K | Buy |
4,890
+1,241
| +34% | +$4.68K | ﹤0.01% | 725 |
|
|
2025
Q1 | $16.5K | Hold |
3,649
| – | – | ﹤0.01% | 748 |
|
|
2024
Q4 | $25.8K | Hold |
3,649
| – | – | ﹤0.01% | 668 |
|
|
2024
Q3 | $29.7K | Hold |
3,649
| – | – | ﹤0.01% | 641 |
|
|
2024
Q2 | $23.3K | Buy |
3,649
+1,621
| +80% | +$10.4K | ﹤0.01% | 638 |
|
|
2024
Q1 | $15.3K | Hold |
2,028
| – | – | ﹤0.01% | 586 |
|
|
2023
Q4 | $18.8K | Sell |
2,028
-217
| -10% | -$2.01K | ﹤0.01% | 544 |
|
|
2023
Q3 | $22.7K | Hold |
2,245
| – | – | ﹤0.01% | 511 |
|
|
2023
Q2 | $28.1K | Hold |
2,245
| – | – | ﹤0.01% | 462 |
|
|
2023
Q1 | $26.2K | Buy |
2,245
+748
| +50% | +$8.73K | ﹤0.01% | 479 |
|
|
2022
Q4 | $15.9K | Buy |
1,497
+28
| +2% | +$298 | ﹤0.01% | 430 |
|
|
2022
Q3 | $14K | Buy |
1,469
+45
| +3% | +$429 | ﹤0.01% | 428 |
|
|
2022
Q2 | $21K | Buy |
1,424
+265
| +23% | +$3.91K | ﹤0.01% | 408 |
|
|
2022
Q1 | $30K | Buy |
1,159
+1,008
| +668% | +$26.1K | ﹤0.01% | 432 |
|
|
2021
Q4 | $6K | Buy |
151
+8
| +6% | +$318 | ﹤0.01% | 635 |
|
|
2021
Q3 | $7K | Buy |
+143
| New | +$7K | ﹤0.01% | 630 |
|